ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,282.70
0.13%
Dow Jones
39,142.23
-1.33%
US Dollar vs MXN
19.71941
0.00%
Brent Oil
67.075
0.00%
Bitcoin
85,186.92
0.15%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. BeiGene Ltd (ONC) Cotización

BeiGene Ltd

BeiGene Ltd (ONC)

Oncimmune Holdings Plc
Oncolytics Biotech Inc
230.98
2.84
(1.24%)
Cerrado 19 Abril 3:00PM
Delayed by 15 minutes
229.75
-1.23
(-0.53%)
Fuera de horario: 6:59PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
230.98
Postura de Compra
226.00
Postura de Venta
281.00
Volume Operado de la Acción
519,865
227.3961 Rango del Día 234.15
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
24.65B
Precio Anterior
228.14
Precio de Apertura
229.30
Hora
42800
@
230.98
(priorref)
Última hora de negociación
Volumen financiero
US$ 119,803,622
Precio Promedio Ponderado
230.4514
Volumen promedio (3 m)
-
Acciones en circulación
106,720,593
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.64
Beneficio por acción (BPA)
-6.04
turnover
3.81B
Beneficio neto
-644.79M

Acerca de BeiGene Ltd

BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system ... BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.beigene.com
Sede
Grand Cayman, Cym
Fundado
-
BeiGene Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ONC. The last closing price for BeiGene was US$228.14. Over the last year, BeiGene shares have traded in a share price range of US$ 0.00 to US$ 0.00.

BeiGene currently has 106,720,593 shares in issue. The market capitalisation of BeiGene is US$24.35 billion. BeiGene has a price to earnings ratio (PE ratio) of -2.64.

ONC Últimas noticias

Más noticias

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
14 Abril 2025
ONC (1.24%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 Abril 2025
ONC (1.24%)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ONC - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de BeiGene?
El precio actual de las acciones de BeiGene es US$ 230.98
¿Cuántas acciones de BeiGene están en circulación?
BeiGene tiene 106,720,593 acciones en circulación
¿Cuál es la capitalización de mercado de BeiGene?
La capitalización de mercado de BeiGene es USD 24.35B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de BeiGene?
BeiGene ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de BeiGene?
El ratio precio/beneficio de BeiGene es -2.64
¿Cuál es el ratio de efectivo a ventas de BeiGene?
El ratio de efectivo a ventas de BeiGene es 0.45
¿Cuál es la moneda de reporte de BeiGene?
BeiGene presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de BeiGene?
El último ingresos anual de BeiGene es USD 3.81B
¿Cuál es el último beneficio anual de BeiGene?
El último beneficio anual de BeiGene es USD -644.79M
¿Cuál es la dirección registrada de BeiGene?
La dirección registrada de BeiGene es 94 SOLARIS AVENUE, CAMANA BAY, PO BOX 1348, GRAND CAYMAN, KY1 1104
¿Cuál es la dirección del sitio web de BeiGene?
La dirección del sitio web de BeiGene es www.beigene.com
¿En qué sector industrial opera BeiGene?
BeiGene opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MSGMMotorsport Games Inc
US$ 2.69
(140.18%)
37M
SXTCChina SXT Pharmaceuticals Inc
US$ 2.11
(113.37%)
51.73M
ADGMAdagio Medical Holdings Inc
US$ 1.68
(81.98%)
115.48M
PNBKPatriot National Bancorp Inc
US$ 3.28
(73.54%)
1.57M
RTCBaijiayun Group Ltd
US$ 0.3601
(67.49%)
187.02M
LXEHLixiang Education Holding Company Ltd
US$ 8.25
(-64.11%)
1.55M
CLIKClick Holdings Ltd
US$ 0.355
(-48.18%)
13.52M
IOTRiOThree Ltd
US$ 1.1409
(-38.33%)
3.93M
FMTOFemto Technologies Inc
US$ 0.0191
(-35.47%)
198.4M
SISIShineco Inc
US$ 0.5809
(-35.07%)
824.91k
DMNDamon Inc
US$ 0.0034
(9.68%)
409.39M
STSSSharps Technology Inc
US$ 0.03195
(20.57%)
391.8M
SUNESUNation Energy Inc
US$ 0.0176
(-10.20%)
349.4M
NVDANVIDIA Corporation
US$ 101.49
(-2.87%)
292.48M
HTZHertz Global Holdings Inc
US$ 8.205
(43.70%)
266.91M

Discusión

Ver feed completo
dinogreeves dinogreeves 4 minutos hace
Bravo, very good post.
GCAN
KevGee59 KevGee59 5 minutos hace
Nope, you just need to have the cash needed to cover the cover the value of the put if sold. Reference "cash secured puts"
I know this...and everyone else should know it too. But my post was answering the the post before that said there was a need for Shorting if you had Puts. But there is no
NWBO
Hoskuld Hoskuld 7 minutos hace
What you wrote may or may not be true in terms of DPZ MOA. It doesn't matter. Both placebo and drug groups were receiving SOC so it equalizes out. If what you wrote were true then you would expect very little difference between drug and placebo arms, but in fact we saw the best results ever seen
DPZ
gfp927z gfp927z 8 minutos hace
Om, Here's some footage from that show -



https://www.youtube.com/watch?v=eAUA_ZTGwfY



---
Whalatane Whalatane 8 minutos hace
Tats. speaking of Easy-E ( Ezetimbe ) otherwise known as Zetia ....it's a small pill and easy to take .
Since Kaiser is currently unable to fill Repatha scripts ( dont know if thats a tariff thing or not ) ....and insists patients like me pay full price for Inclisiran ( Leqvivo )..the other
AMRN
Genz2 Genz2 9 minutos hace
I have heard it’s good to walk a mile in someone’s shoes!!! I think if people walked 5 miles in Elon’s shoes, they wouldn’t have survived to see almost every car company now has an EV, they wouldn’t have been alive to help eliminate the corruption in our government, save two astronauts, provide a p
TSLA
DMC8 DMC8 9 minutos hace
Annual report 2024 filed (UK)
https://find-and-update.company-information.service.gov.uk/company/02353920/filing-history
AMRN
janetcanada janetcanada 10 minutos hace
☯️***GCAN***I Copy From Google!.....I Enter the Question And I Copy The Reply!!!!.....
Sometime It Is Easiest Than Other!...MY MY!!!😜-

***Shall I Send You My Italian Birthday Certificate???....
GCAN
SkyLimit2022 SkyLimit2022 11 minutos hace
Good points! Maybe the discussion will inspire some to research this issue more in advance of any potential catalyst(s).

An AI app made a flyer on this topic:

https://investorshub.advfn.com/uimage/uploads/2025/4/19/wotndIMG_1673.jpeg

https://investors
NWBO
danieldeubank danieldeubank 11 minutos hace
China is up to its old tricks and will be caught red handed by the 232 actions.

https://www.linkedin.com/posts/rare-earth-exchanges_rareearth-chinaeconomy-criticalminerals-activity-7319217923242307584-bUek?utm_medium=ios_app&rcm=ACoAAAcgj48BT9F7PUhNWxJ6hOp1KI16ThOcHBM&utm_source=socia
NB
okwife okwife 11 minutos hace
am i getting this straight we had to have reno refiners legitimize the bishop mill refiner
and that is what took so long to become profitable here?
"$NBRI two shipments of gold concentrate to Just Refiners in Reno was a beta test, a trial run, to prove and improve upon their milling o
NBRI
dewophile dewophile 12 minutos hace
Efficacy wise this seems like xolair and not in the same ballpark as other agents in development especially kit (cldx data). Will be interesting to see how the market shakes out there is a lot of activity here as you know. NVS thinks the market opportunity is way bigger than the 300k mentioned in th
arizona1 arizona1 12 minutos hace
This Democratic Party Vice Chair wants to get rid of Democrats who "roll over and die"

David Hogg is not fooling around.

The recently elected Vice Chair of the Democratic National Committee, the group responsible for overseeing the operations of the national Democratic
danieldeubank danieldeubank 13 minutos hace
Go NioCorp!
NB
VVVVVV VVVVVV 15 minutos hace
Probably wishful thinking. Not sure if that’s an option anymore. If it were, that would be very interesting .

This has turned into a gamble, not an investment. The roulette wheel will start to spin next week. Will it stop on black or red, nobody really knows.

We
VPLM
Its_TradingG Its_TradingG 16 minutos hace
Picking apart more of your lies:

BTW, the legal matter has been filed now

Why are you asking people on X if they want to be “plaintiff’s”?

https://x.com/supertabra55141/status/1913408583540048116?s=46

If docsetc’s case was actually fi
ENZC
Atomic_Insider Atomic_Insider 16 minutos hace
Or it will collapse to 70$ instantly, overhyped trillion dollar airtank
NVDA
GrandAdmiralThrawn GrandAdmiralThrawn 16 minutos hace
Janet, I know you ain’t talking with your non speaking correct English self, or do you only know how to write English only when it’s convenient to you?
At the end of the day, the big following users here have led many astray because of unrealistic expectations. So now these same users are in
GCAN
janice shell janice shell 17 minutos hace
Oooh, that's a nice one!! I'm sure it'll be very popular!!
penguin007 penguin007 17 minutos hace
I'm holding, and with nothing lost. 
ZHUD
jimr1717 jimr1717 18 minutos hace
Cons conning cons
HMBL
jimmy667 jimmy667 21 minutos hace
Yes that is true. Loaning shares to shorts in a short target stock like NWBO is just plain ignorant. But putting in stop loss order triggers is full on stupid. The MM can see those stops in the order books and they trigger a market sell order so the MMer can drop the price way down fill the market o
NWBO
StockItOut StockItOut 21 minutos hace
hence you were prolific in "hateful rhetoric on ihub."

lol


(just go back and read your years and years of posts on ihub, which confirms)

flip flopper!
MDCE
mrwrn2010 mrwrn2010 22 minutos hace
Not by my PC yet, any cliffs notes? Purdue doing the usual bullshizzing running out the clock?
ELTP
Bullrunner2 Bullrunner2 23 minutos hace
It was not me, since I sold at 13. But I convinced another 100k shareholder to sell at 20 for 2m and buy 1000 $20 strikes instead for 300k. This way, his maximum loss was 300k instead of riding back to 3, which I saw as possible if they lost the case. I was unable to convince another 100k holder to
AMRN

Su Consulta Reciente

NASDAQ
ONC
BeiGene
Delayed Upgrade Clock
ADVFN Logo
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios